
DexCom Inc (DXCM) - Financial and Strategic SWOT Analysis Review
Description
DexCom Inc (DXCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Dexcom Inc (Dexcom) designs, develops and commercializes continuous glucose monitoring (CGM) systems used by people with diabetes and healthcare providers in the hospital. The company’s major products include integrated Dexcom G6 CGM system, Dexcom Share remote monitoring system, Dexcom Real-Time API, Dexcom ONE CGM system, associated software and mobile apps. It provides Dexcom Care training to users of CGM system and other support services. The company offers products to endocrinologists, physicians, diabetes educators and others. It distributes products directly in the US, Austria, Canada, Germany, Switzerland and the UK, and also through a network of distributors in Australia, the US, New Zealand, and other countries in Asia, Europe, Africa, Latin America, and the Middle East. Dexcom is headquartered in San Diego, California, the US.
DexCom Inc Key Recent Developments
Jul 30,2025: Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan
Jul 17,2025: Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews
Jul 01,2025: DexCom Second Quarter 2025 Earnings Release Conference Call
May 14,2025: Dexcom Wastewater Treatment Plant, Athenry, Co Galway
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Dexcom Inc (Dexcom) designs, develops and commercializes continuous glucose monitoring (CGM) systems used by people with diabetes and healthcare providers in the hospital. The company’s major products include integrated Dexcom G6 CGM system, Dexcom Share remote monitoring system, Dexcom Real-Time API, Dexcom ONE CGM system, associated software and mobile apps. It provides Dexcom Care training to users of CGM system and other support services. The company offers products to endocrinologists, physicians, diabetes educators and others. It distributes products directly in the US, Austria, Canada, Germany, Switzerland and the UK, and also through a network of distributors in Australia, the US, New Zealand, and other countries in Asia, Europe, Africa, Latin America, and the Middle East. Dexcom is headquartered in San Diego, California, the US.
DexCom Inc Key Recent Developments
Jul 30,2025: Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan
Jul 17,2025: Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews
Jul 01,2025: DexCom Second Quarter 2025 Earnings Release Conference Call
May 14,2025: Dexcom Wastewater Treatment Plant, Athenry, Co Galway
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
52 Pages
- Section 1 - About the Company
- DexCom Inc - Key Facts
- DexCom Inc - Key Employees
- DexCom Inc - Key Employee Biographies
- DexCom Inc - Major Products and Services
- DexCom Inc - History
- DexCom Inc - Company Statement
- DexCom Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- DexCom Inc - Business Description
- Geographical Segment: International
- Performance
- Geographical Segment: United States
- Performance
- R&D Overview
- DexCom Inc - Corporate Strategy
- DexCom Inc - SWOT Analysis
- SWOT Analysis - Overview
- DexCom Inc - Strengths
- DexCom Inc - Weaknesses
- DexCom Inc - Opportunities
- DexCom Inc - Threats
- DexCom Inc - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- DexCom Inc, Medical Equipment, Deals By Year, 2019 to YTD 2025
- DexCom Inc, Medical Equipment, Deals By Type, 2019 to YTD 2025
- DexCom Inc, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Jul 30, 2025: Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan
- Jul 17, 2025: Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews
- Jul 01, 2025: DexCom Second Quarter 2025 Earnings Release Conference Call
- May 14, 2025: Dexcom Wastewater Treatment Plant, Athenry, Co Galway
- May 13, 2025: Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO
- Apr 03, 2025: Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time
- Mar 25, 2025: Dexcom Appoints Jon Coleman as Chief Commercial Officer
- Mar 10, 2025: Dexcom Appoints Renee Gala to Board of Directors
- Mar 07, 2025: DexCom : Fiscal Year 2025 Guidance for Revenue Previously Issued on February 13, 2025
- Jan 13, 2025: Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- DexCom Inc, Key Facts
- DexCom Inc, Key Employees
- DexCom Inc, Key Employee Biographies
- DexCom Inc, Major Products and Services
- DexCom Inc, History
- DexCom Inc, Subsidiaries
- DexCom Inc, Key Competitors
- DexCom Inc, Ratios based on current share price
- DexCom Inc, Annual Ratios
- DexCom Inc, Annual Ratios (Cont...1)
- DexCom Inc, Annual Ratios (Cont...2)
- DexCom Inc, Interim Ratios
- DexCom Inc, Medical Equipment, Deals By Year, 2019 to YTD 2025
- DexCom Inc, Medical Equipment, Deals By Type, 2019 to YTD 2025
- DexCom Inc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- DexCom Inc, Performance Chart (2020 - 2024)
- DexCom Inc, Ratio Charts
- DexCom Inc, Medical Equipment, Deals By Year, 2019 to YTD 2025
- DexCom Inc, Medical Equipment, Deals by Type, 2019 to YTD 2025
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.